BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38525660)

  • 1. Contemporary Diagnostic Reporting for Prostatic Adenocarcinoma: Morphologic Aspects, Molecular Correlates, and Management Perspectives.
    Muthusamy S; Smith SC
    Adv Anat Pathol; 2024 May; 31(3):188-201. PubMed ID: 38525660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
    Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.
    Paner GP; Gandhi J; Choy B; Amin MB
    Arch Pathol Lab Med; 2019 May; 143(5):550-564. PubMed ID: 30865487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
    Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
    Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer: Update on Grading and Reporting.
    Baraban E; Epstein J
    Surg Pathol Clin; 2022 Dec; 15(4):579-589. PubMed ID: 36344176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in prostate cancer pathology: Gleason grading and beyond.
    Shah RB; Zhou M
    Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
    Silva-Rodríguez J; Colomer A; Sales MA; Molina R; Naranjo V
    Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present and future of prostate cancer histopathology.
    McKenney JK
    Curr Opin Urol; 2017 Sep; 27(5):464-468. PubMed ID: 28614086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: from Gleason scoring to prognostic grade grouping.
    Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
    Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
    McKenney JK; Wei W; Hawley S; Auman H; Newcomb LF; Boyer HD; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Tretiakova MS; Vakar-Lopez F; Carroll PR; Cooperberg MR; Gleave ME; Lance RS; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; Brooks JD
    Am J Surg Pathol; 2016 Nov; 40(11):1439-1456. PubMed ID: 27635949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists.
    Singh RV; Agashe SR; Gosavi AV; Sulhyan KR
    Indian J Cancer; 2011; 48(4):488-95. PubMed ID: 22293266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
    Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
    Ann Diagn Pathol; 2021 Jun; 52():151733. PubMed ID: 33780691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
    Oyama T; Allsbrook WC; Kurokawa K; Matsuda H; Segawa A; Sano T; Suzuki K; Epstein JI
    Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.